Alumis ALMS
NASDAQ ALMS
$11.08 -0.28 (-2.46%)
As of: Sep 4, 2026 · 3:18 PM EDT

Alumis (ALMS) Other Non-Current Assets (2023 - 2026)

Alumis (ALMS) posted quarterly Other Non-Current Assets of $1.3 million for Q4 2025, up 18485.71% year-over-year from N/an in Q4 2024, and down 5.17% quarter-over-quarter from $1.4 million in Q3 2025.

Analysis

Alumis (ALMS) Other Non-Current Assets (2023 - 2026) Analysis & Trends

Alumis (ALMS) has reported Other Non-Current Assets for 3 consecutive years, with $1.3 million the latest figure, recorded in Q4 2025.

  • In Q4 2025, Other Non-Current Assets rose 18485.71% year-over-year to $1.3 million; the TTM figure through Dec 2025 stood at $1.3 million (up 18485.71% YoY), while the FY2025 annual figure was $1.3 million, up 18485.71% from the prior year.
  • Other Non-Current Assets declined to $1.3 million in Q4 2025 per ALMS's latest filing, from $1.4 million in the prior quarter.
  • Across five years, Other Non-Current Assets topped out at $2.5 million in Q2 2025 and bottomed at $7000.0 in Q4 2024.
  • Historically, Other Non-Current Assets has averaged $1.0 million across 3 years, with a median of $1.0 million in 2023.
  • Annual changes were most pronounced in 2024 — Other Non-Current Assets plunged 99.32% — and 2025, when it soared 18485.71%.
  • Alumis' Other Non-Current Assets stood at $1.0 million in 2023, then slumped by 99.32% to $7000.0 in 2024, then jumped by 18485.71% to $1.3 million in 2025.
  • Business Quant data shows ALMS's Other Non-Current Assets at $1.3 million in Q4 2025, $1.4 million in Q3 2025, and $2.5 million in Q2 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Other Non-Current Assets (Qtr)
1 Vertex Pharmaceuticals 138.51 Bn 130.66 Bn 2.84 Bn 1.25 Bn
2 Regeneron Pharmaceuticals 85.24 Bn 77.25 Bn 3.93 Bn 2.31 Bn
3 Argenx Se 63.46 Bn 58.28 Bn 1.37 Bn 124.00 Mn
4 Moderna 57.89 Bn 52.75 Bn 52.00 Mn 618.00 Mn
5 Revolution Medicines 44.02 Bn 44.02 Bn - 42.45 Mn
6 BeOne Medicines 39.95 Bn 34.85 Bn 1.53 Bn 109.58 Mn
7 Alnylam Pharmaceuticals 35.49 Bn 32.19 Bn 992.69 Mn 65.13 Mn
8 Royalty Pharma 28.43 Bn 27.59 Bn - 62.96 Mn
9 Insmed 27.39 Bn 26.22 Bn 358.27 Mn 104.44 Mn
10 Alumis 1.41 Bn 907.50 Mn - 1.89 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 1.89 Mn
Dec 31, 2025 6.29 Mn
Sep 30, 2025 5.82 Mn
Jun 30, 2025 1.38 Mn
Mar 31, 2025 1.16 Mn
Dec 31, 2024 1.11 Mn
Sep 30, 2024 1.02 Mn
Jun 30, 2024 1.02 Mn
Mar 31, 2024 1.02 Mn
Dec 31, 2023 1.02 Mn
Sep 30, 2023 1.02 Mn
Jun 30, 2023 1.14 Mn